Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2005
A zebrafish bmyb mutation causes genome instability and increased cancer susceptibilityJennifer L Shepard, James F Amatruda, Howard M Stern, et al.
Human Molecular Genetics|March 26, 2015
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility lociSimon G Coetzee, Howard C Shen, Dennis J Hazelett, et al.
The Prostate|May 6, 2021
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancerVictoria Wang, Milan S Geybels, Kristina M Jordahl, et al.
Research Square|April 22, 2024
Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiencyZoltan Szallasi, Miklos Diossy, Viktoria Tisza, et al.
Human Genetics|February 3, 2009
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE StatementJulian Little, Julian P T Higgins, John P A Ioannidis, et al.
Plos Medicine|February 6, 2009
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statementJulian Little, Julian P T Higgins, John P A Ioannidis, et al.
Ebiomedicine|February 5, 2016
A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American menGyorgy Petrovics, Hua Li, Tanja Stümpel, et al.
Journal of Clinical Epidemiology|February 17, 2009
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statementJulian Little, Julian P T Higgins, John P A Ioannidis, et al.
Genetic Epidemiology|March 12, 2009
STrengthening the REporting of Genetic Association Studies (STREGA)--an extension of the STROBE statementJulian Little, Julian P T Higgins, John P A Ioannidis, et al.
Trials|February 2, 2017
ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trialDavid A Drew, Samantha M Chin, Katherine K Gilpin, et al.
Pageof 6